{"id":"https://openalex.org/W2016325373","doi":"https://doi.org/10.1159/000094727","title":"Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients","display_name":"Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients","alternate_titles":[],"publication_year":2006,"publication_date":"2006-08-02","ids":{"openalex":"https://openalex.org/W2016325373","doi":"https://doi.org/10.1159/000094727","mag":"2016325373","pmid":"https://pubmed.ncbi.nlm.nih.gov/16874005"},"language":"en","primary_location":{"id":"doi:10.1159/000094727","doi":"https://doi.org/10.1159/000094727","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000094727","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016325373"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032624282","display_name":"Masaki Kato","orcid":"https://orcid.org/0000-0001-6727-7272","observed_orcids":["https://orcid.org/0000-0001-6727-7272"]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki Kato","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan. pangaea1975@yahoo.co.jp","Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan. pangaea1975@yahoo.co.jp","institution_ids":["https://openalex.org/I126884977"]},{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013881333","display_name":"Tsuyoshi Fukuda","orcid":"https://orcid.org/0000-0002-0477-3102","observed_orcids":["https://orcid.org/0000-0002-0477-3102"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsuyoshi Fukuda","raw_affiliation_strings":["Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030746826","display_name":"Masataka Wakeno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masataka Wakeno","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068255029","display_name":"Kazuhiro Fukuda","orcid":"https://orcid.org/0000-0003-2999-5542","observed_orcids":["https://orcid.org/0000-0003-2999-5542"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiro Fukuda","raw_affiliation_strings":["Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087281969","display_name":"Gaku Okugawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Gaku Okugawa","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110058877","display_name":"Yuka Ikenaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuka Ikenaga","raw_affiliation_strings":["Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Megumi Yamashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Megumi Yamashita","raw_affiliation_strings":["Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009945280","display_name":"Yoshiteru Takekita","orcid":"https://orcid.org/0000-0003-2435-4033","observed_orcids":["https://orcid.org/0000-0003-2435-4033"]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiteru Takekita","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075740693","display_name":"Kenji Nobuhara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Nobuhara","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029185764","display_name":"Junichi Azuma","orcid":"https://orcid.org/0000-0001-8758-8537","observed_orcids":["https://orcid.org/0000-0001-8758-8537"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junichi Azuma","raw_affiliation_strings":["Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058118992","display_name":"Toshihiko Kinoshita","orcid":"https://orcid.org/0000-0001-9901-9753","observed_orcids":["https://orcid.org/0000-0001-9901-9753"]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihiko Kinoshita","raw_affiliation_strings":["Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropsychiatry, Kansai Medical University, Moriguchi, and","institution_ids":["https://openalex.org/I126884977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.11,"has_fulltext":false,"cited_by_count":178,"citation_normalized_percentile":{"value":0.96689526,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"53","issue":"4","first_page":"186","last_page":"195"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7217000126838684,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.24490000307559967,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-receptor-gene","display_name":"serotonin receptor gene","score":0.8199999928474426},{"id":"https://openalex.org/keywords/htr2a","display_name":"HTR2A","score":0.8209999799728394},{"id":"https://openalex.org/keywords/htr3a","display_name":"HTR3A","score":1.0},{"id":"https://openalex.org/keywords/htr3b","display_name":"HTR3B","score":1.0},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9179999828338623},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.7900000214576721},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9639999866485596},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.9369999766349792},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.6620000004768372},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.9088488817214966},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.9066476225852966},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.7950677871704102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6057605147361755},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.603374183177948},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5722900629043579},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5097074508666992},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5015771389007568},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.46570736169815063},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.44387608766555786},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4356034994125366},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34870362281799316},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.34244441986083984},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3375169336795807},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2530379891395569},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.21246376633644104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20710116624832153},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.15316063165664673},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11299589276313782},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10160917043685913},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D044348","descriptor_name":"Receptors, Serotonin, 5-HT2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000094727","doi":"https://doi.org/10.1159/000094727","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000094727","pdf_url":null,"source":{"id":"https://openalex.org/S147539111","display_name":"Neuropsychobiology","issn_l":"0302-282X","issn":["0302-282X","1423-0224"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"journal-article"},{"id":"pmid:16874005","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16874005","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychobiology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310756","display_name":"Japan Research Foundation for Clinical Pharmacology","ror":"https://ror.org/02900by63"},{"id":"https://openalex.org/F4320310759","display_name":"Nakatomi Foundation","ror":"https://ror.org/0196vdc40"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W96283296","https://openalex.org/W1786663574","https://openalex.org/W1923513268","https://openalex.org/W1966424565","https://openalex.org/W1969996445","https://openalex.org/W1974267427","https://openalex.org/W1974600533","https://openalex.org/W1975570987","https://openalex.org/W1977160269","https://openalex.org/W1980676016","https://openalex.org/W1984802541","https://openalex.org/W1992428231","https://openalex.org/W1997010275","https://openalex.org/W1998110762","https://openalex.org/W2005534453","https://openalex.org/W2010894744","https://openalex.org/W2015907833","https://openalex.org/W2016840143","https://openalex.org/W2018658097","https://openalex.org/W2034287575","https://openalex.org/W2036626695","https://openalex.org/W2043557429","https://openalex.org/W2046506777","https://openalex.org/W2047200908","https://openalex.org/W2050763807","https://openalex.org/W2053110423","https://openalex.org/W2057162218","https://openalex.org/W2062113276","https://openalex.org/W2070861572","https://openalex.org/W2082981647","https://openalex.org/W2083043080","https://openalex.org/W2084965184","https://openalex.org/W2090235055","https://openalex.org/W2090977130","https://openalex.org/W2096091943","https://openalex.org/W2098760758","https://openalex.org/W2103901309","https://openalex.org/W2106095564","https://openalex.org/W2111424618","https://openalex.org/W2116152046","https://openalex.org/W2116329478","https://openalex.org/W2118394214","https://openalex.org/W2120383646","https://openalex.org/W2136749432","https://openalex.org/W2136825478","https://openalex.org/W2137296158","https://openalex.org/W2140425130","https://openalex.org/W2149910284","https://openalex.org/W2150274550","https://openalex.org/W2156270847","https://openalex.org/W2157348278","https://openalex.org/W2159011576","https://openalex.org/W2329661970"],"related_works":["https://openalex.org/W1975570987","https://openalex.org/W2031690017","https://openalex.org/W1992013234","https://openalex.org/W1984802541","https://openalex.org/W2098760758","https://openalex.org/W2050763807","https://openalex.org/W2052576618","https://openalex.org/W2073804401","https://openalex.org/W2005524713","https://openalex.org/W2106510562"],"abstract_inverted_index":{"In":[0],"this":[1],"study,":[2],"we":[3],"tested":[4],"the":[5,8,26,30,36,70,88,144,173,176,197,200,211,227],"influence":[6],"of":[7,29,39,48,91,113,143,168,213,229],"serotonin":[9,31],"type":[10],"2A,":[11],"3A":[12],"and":[13,34,44,77,129,155,191,199,222],"3B":[14],"receptor":[15],"genes":[16],"(HTR2A,":[17],"HTR3A,":[18],"HTR3B)":[19],"in":[20,25,59,134,158],"addition":[21],"to":[22,42,97,108,121,127,184,220],"a":[23,60,94,118,182],"polymorphism":[24,178,202],"promoter":[27],"region":[28],"transporter":[32],"(SERTPR),":[33],"investigated":[35],"different":[37],"characteristics":[38,228],"clinical":[40,65],"responses":[41],"paroxetine":[43],"fluvoxamine.":[45,109],"A":[46],"total":[47],"100":[49],"Japanese":[50],"patients":[51,136,160],"affected":[52],"by":[53],"major":[54],"recurrent":[55],"depression":[56],"were":[57,81,166],"enrolled":[58],"randomized":[61],"6-week":[62],"study.":[63],"The":[64,110,140],"response":[66,96,120,151,183],"was":[67,115,146,179],"evaluated":[68],"using":[69],"Hamilton":[71],"Rating":[72],"Scale":[73],"for":[74],"Depression":[75],"(HAM-D),":[76],"adverse":[78,207],"drug":[79,208],"reactions":[80],"assessed":[82],"at":[83],"each":[84,230],"visit.":[85],"Patients":[86],"with":[87,117,131,148,181,196,206],"l":[89],"allele":[90],"SERTPR":[92],"showed":[93],"better":[95],"SSRIs":[98,122],"than":[99],"s/s":[100],"genotype":[101,112,142],"carriers":[102],"(p":[103,123,137,152,161],"=":[104,124,138,153,162],"0.015-0.042),":[105],"more":[106,156],"significantly":[107,130,157],"-1438G/G":[111],"HTR2A":[114,190,201],"associated":[116,147,180,195,205],"good":[119],"0.010-0.039),":[125],"especially":[126],"fluvoxamine,":[128],"severe":[132],"nausea":[133],"paroxetine-treated":[135,159],"0.013).":[139],"178C/C":[141],"HTR3A":[145,192],"an":[149],"antidepressant":[150],"0.022-0.042),":[154],"0.002-0.042).":[163],"These":[164],"effects":[165,212],"independent":[167],"one":[169,218],"another.":[170],"We":[171,186],"replicated":[172],"finding":[174],"that":[175,189],"SERPTR":[177],"SSRIs.":[185],"additionally":[187],"found":[188],"polymorphisms":[193,215],"are":[194],"efficacy,":[198],"is":[203],"also":[204],"reactions.":[209],"Furthermore,":[210],"these":[214],"varied":[216],"from":[217],"SSRI":[219],"another":[221],"thus":[223],"may":[224],"depend":[225],"on":[226],"SSRI.":[231]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016325373","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
